CIRRUS

This brand name is authorized in Estonia, Finland, Lithuania, Malta, Poland, South Africa

Active ingredients

The drug CIRRUS contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII 64O047KTOA - CETIRIZINE HYDROCHLORIDE
 

Cetirizine, a human metabolite of hydroxyzine, is a potent and selective antagonist of peripheral H1-receptors. In vitro receptor binding studies have shown no measurable affinity for other than Η1-receptors.

 
Read more about Cetirizine
2
UNII 6V9V2RYJ8N - PSEUDOEPHEDRINE HYDROCHLORIDE
 

Pseudoephedrine is a sympathomimetic agent with direct and indirect effects on adrenergic receptors. It has alpha and beta adrenergic activity and some stimulant effect on the central nervous system. The sympathomimetic effect of pseudoephedrine produces vasoconstriction which in turn relieves nasal congestion.

 
Read more about Pseudoephedrine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
R01BA52 Pseudoephedrine, combinations R Respiratory system → R01 Nasal preparations → R01B Nasal decongestants for systemic use → R01BA Sympathomimetics
Discover more medicines within R01BA52

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1141311, 1141322
FI Lääkealan turvallisuus- ja kehittämiskeskus 014905, 014949
LT Valstybinė vaistų kontrolės tarnyba 1017353, 1093136
MT Medicines Authority MA030/00801, PI908/17202A
PL Rejestru Produktów Leczniczych 100118460, 100375895
ZA Health Products Regulatory Authority 33/5.8/0317

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.